Geeta Raman Kutty, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location · San Jose Gastroenterology, Inc. · 11 clinicians in this group
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kutty’s office at (408) 347-9001 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A158918 · Current
Licensed to practise in California · since 2018 · expires 2028-10-31 · Dr. D.Y. Patil Vidyapeeth, Pune, Dr. D.Y. Patil Medical College for Women.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$73,610
Medicare paid this office $73,610 for 213 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 75 | $11,413 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $11,343 | $227 |
| Pathology examination of tissue using a microscope, intermediate complexity | 123 | $10,045 | $39 |
| New patient visit (45+ min) | 68 | $9,305 | $137 |
| Biopsy of large bowel using a flexible endoscope | 60 | $7,380 | $121 |
See all 10 services
| Return visit (30+ min) | 75 | $11,413 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $11,343 | $227 |
| Pathology examination of tissue using a microscope, intermediate complexity | 123 | $10,045 | $39 |
| New patient visit (45+ min) | 68 | $9,305 | $137 |
| Biopsy of large bowel using a flexible endoscope | 60 | $7,380 | $121 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 62 | $5,930 | $86 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $3,036 | $95 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,549 | $159 |
| New patient visit (30+ min) | 13 | $1,203 | $93 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 26 | $123 | $5 |
Procedures Medicare counted
| Colonoscopy | 131 | More than 86% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 78 | More than 72% of doctors who do this |
Who their Medicare patients are
213 Original Medicare patients in 2024. Average age 73 · Under 65 6% · 85 and older 6% · Women 68% · Also on Medicaid 31% · Health risk score 1.11. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 73% · Coronary heart disease 30% · Diabetes 29% · Chronic kidney disease 21% · Depression 18% · Cancer 14% · Atrial fibrillation 14% · Heart failure 11% · COPD 10% · Stroke 6%.
The office billed $355,213, Medicare allowed $95,255 and paid $73,610; for 767 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 213 | 767 | 73 | 1.11 | $355,213 | $73,610 |
| 2023 | 238 | 810 | 74 | 1.13 | $307,273 | $78,857 |
| 2022 | 240 | 864 | 73 | 1.45 | $315,620 | $83,402 |
| 2021 | 269 | 834 | 74 | 1.64 | $287,957 | $84,333 |
| 2020 | 253 | 651 | 76 | 2.54 | $227,328 | $70,662 |
| 2019 | 257 | 917 | 74 | 2.05 | $310,313 | $95,468 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| New patient visit (45+ min) | 87 | $12,930 | $149 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 56 | $12,591 | $221 |
| Pathology examination of tissue using a microscope, intermediate complexity | 119 | $10,131 | $39 |
| Biopsy of large bowel using a flexible endoscope | 59 | $6,492 | $110 |
| Return visit (30+ min) | 45 | $5,895 | $120 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $5,176 | $83 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $3,373 | $147 |
| Special stained specimen slides to identify organisms including interpretation and report | 15 | $2,697 | $96 |
| New patient visit (30+ min) | 22 | $2,092 | $95 |
| Short return visit (20+ min) | 19 | $1,853 | $77 |
| New patient visit (15+ min) | 12 | $848 | $71 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 37 | $175 | $5 |
2022: 13 services
| New patient visit (45+ min) | 84 | $12,637 | $150 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $11,127 | $232 |
| Pathology examination of tissue using a microscope, intermediate complexity | 102 | $8,750 | $37 |
| Return visit (30+ min) | 56 | $7,659 | $114 |
| Biopsy of large bowel using a flexible endoscope | 56 | $5,811 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $5,465 | $78 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,203 | $210 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,163 | $173 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $3,466 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,158 | $93 |
| New patient visit (30+ min) | 23 | $2,343 | $102 |
| Short return visit (20+ min) | 19 | $1,848 | $84 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 46 | $209 | $4 |
2021: 14 services
| New patient visit (45+ min) | 69 | $10,729 | $155 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $9,865 | $235 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,561 | $180 |
| Pathology examination of tissue using a microscope, intermediate complexity | 71 | $6,989 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,234 | $94 |
| Biopsy of large bowel using a flexible endoscope | 50 | $4,845 | $97 |
| Return visit (30+ min) | 31 | $4,662 | $126 |
| Short return visit (20+ min) | 45 | $4,528 | $79 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $3,703 | $74 |
| New patient visit (30+ min) | 33 | $3,369 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,285 | $66 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,356 | $214 |
| New patient visit (15+ min) | 12 | $864 | $72 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 21 | $106 | $5 |
2020: 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $19,648 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $9,686 | $95 |
| Short return visit (20+ min) | 52 | $5,948 | $65 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $5,055 | $230 |
| New patient visit (45+ min) | 30 | $4,309 | $144 |
| Pathology examination of tissue using a microscope, intermediate complexity | 26 | $3,816 | $48 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,540 | $96 |
| Biopsy of large bowel using a flexible endoscope | 30 | $3,037 | $101 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,551 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,001 | $59 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $64 | $4 |
2019: 16 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,736 | $181 |
| Pathology examination of tissue using a microscope, intermediate complexity | 61 | $11,602 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $10,597 | $93 |
| New patient visit (45+ min) | 60 | $9,085 | $151 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $6,416 | $221 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | $5,288 | $93 |
| Short return visit (20+ min) | 48 | $4,802 | $71 |
| Biopsy of large bowel using a flexible endoscope | 46 | $4,747 | $103 |
| Special stained specimen slides to identify organisms including interpretation and report | 27 | $4,040 | $104 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,330 | $212 |
| Return visit (30+ min) | 16 | $1,748 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,626 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,246 | $113 |
| New patient visit (30+ min) | 11 | $1,122 | $102 |
| New patient visit (10+ min) | 15 | $665 | $44 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 50 | $240 | $5 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 15 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 15 | $0 |
| 2024 | 15 | 1 | 13 | $0 |
| 2023 | 25 | 1 | 13 | $306 |
| 2022 | 26 | 1 | 14 | $91 |
| 2021 | 93 | 6 | 20 | $1,766 |
| 2020 | 106 | 3 | 17 | $2,805 |
| 2019 | 47 | 3 | 15 | $939 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 25 | $306 |
2022
| TISSUE EXAM BY PATHOLOGIST | 26 | $91 |
2021
| New patient visit (45+ min) | 20 | $805 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $593 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $342 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 15 | $26 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $0 |
| New patient visit (30+ min) | 12 | $0 |
2020
| 1ST HOSP IP/OBS HIGH 75 | 57 | $1,939 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 36 | $774 |
| Short return visit (20+ min) | 13 | $92 |
2019
| 1ST HOSP IP/OBS HIGH 75 | 15 | $498 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $376 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $65 |
Drugs they prescribed that Part D paid
$417,912
Pharmacies billed $417,912 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 618) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
479 generic and 139 brand-name prescriptions · $417,912 in drug cost · 34 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 28 | $41,554 | $1,484 |
| Linzess | 17 | $9,064 | $533 |
| Mesalamine | 33 | $9,021 | $273 |
| Sutab | 28 | $4,471 | $160 |
| Omeprazole | 177 | $2,560 | $14 |
See all 9 drugs
| Vemlidy | 28 | $41,554 | $1,484 |
| Linzess | 17 | $9,064 | $533 |
| Mesalamine | 33 | $9,021 | $273 |
| Sutab | 28 | $4,471 | $160 |
| Omeprazole | 177 | $2,560 | $14 |
| Sod Sulf-Potass Sulf-Mag Sulf | 38 | $2,377 | $63 |
| Gavilyte-C | 114 | $2,084 | $18 |
| Pantoprazole | 41 | $928 | $23 |
| Amoxicillin | 11 | $58 | $5 |
Year by year
| 2024 | 618 | 267 | 0% (0) | 22% | $417,912 |
| 2023 | 428 | 182 | 0% (0) | 29% | $190,881 |
| 2022 | 561 | 247 | None | 36% | $161,661 |
| 2021 | 527 | 230 | None | 39% | $92,996 |
| 2020 | 367 | 127 | 0% (0) | 29% | $191,795 |
| 2019 | 332 | 159 | 0% (0) | 33% | $34,987 |
| 2017 | 49 | 28 | None | None | $12,571 |
| 2016 | 21 | 15 | 0% (0) | None | $2,535 |
| 2015 | 12 | None | None | None | $464 |
| 2014 | 106 | None | 0% (0) | 19% | $3,594 |
| 2013 | 65 | None | 0% (0) | None | $1,725 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Vemlidy | 32 | $52,385 | $1,637 |
| Creon | 11 | $33,022 | $3,002 |
| Mesalamine | 24 | $11,537 | $481 |
| Linzess | 11 | $10,414 | $947 |
| Sutab | 40 | $6,740 | $168 |
| Omeprazole | 120 | $3,539 | $29 |
| Sod Sulf-Potass Sulf-Mag Sulf | 24 | $1,847 | $77 |
| Pantoprazole | 49 | $1,378 | $28 |
| Gavilyte-C | 30 | $565 | $19 |
2022: 10 drugs
| Creon | 25 | $56,288 | $2,252 |
| Vemlidy | 40 | $53,028 | $1,326 |
| Linzess | 22 | $15,049 | $684 |
| Mesalamine | 20 | $8,328 | $416 |
| Suprep | 64 | $7,333 | $115 |
| Omeprazole | 134 | $3,320 | $25 |
| Sutab | 13 | $2,106 | $162 |
| Gavilyte-C | 72 | $1,239 | $17 |
| Sod Sulf-Potass Sulf-Mag Sulf | 11 | $895 | $81 |
| Pantoprazole | 45 | $836 | $19 |
2021: 9 drugs
| Vemlidy | 25 | $31,373 | $1,255 |
| Suprep | 118 | $12,841 | $109 |
| Mesalamine | 12 | $5,976 | $498 |
| Omeprazole | 155 | $1,969 | $13 |
| Pantoprazole | 27 | $626 | $23 |
| Peg 3350-Electrolyte | 20 | $440 | $22 |
| Sucralfate | 13 | $365 | $28 |
| Peg-3350 and Electrolytes | 14 | $193 | $14 |
| Lactulose | 17 | $107 | $6 |
2020: 6 drugs
| Vemlidy | 15 | $17,284 | $1,152 |
| Suprep | 47 | $4,867 | $104 |
| Omeprazole | 128 | $1,085 | $8 |
| Sucralfate | 19 | $804 | $42 |
| Pantoprazole | 41 | $332 | $8 |
| Gavilyte-G | 22 | $286 | $13 |
2019: 7 drugs
| Suprep | 45 | $4,433 | $99 |
| Omeprazole | 83 | $952 | $11 |
| Gavilyte-N | 20 | $342 | $17 |
| Peg 3350-Electrolyte | 18 | $324 | $18 |
| Sucralfate | 14 | $309 | $22 |
| Gavilyte-G | 18 | $239 | $13 |
| Ranitidine | 21 | $135 | $6 |
2017: 1 drug
| Levofloxacin | 18 | $92 | $5 |
2014: 2 drugs
| Humulin 70-30 | 11 | $2,000 | $182 |
| Simvastatin | 12 | $91 | $8 |
2013: 1 drug
| Enalapril Maleate | 15 | $118 | $8 |
Money from drug and device companies
$1,048 in 2025
| 2025 | 12 | 37 | None | $1,048 |
| 2024 | 8 | 15 | None | $595 |
| 2023 | 2 | 4 | None | $83 |
| 2022 | 1 | 1 | None | $23 |
| 2021 | 2 | 23 | None | $184 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $188 | 9 payments
|
| Janssen Biotech | Tremfya | $173 | 4 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $117 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $116 | 1 payment
|
| Gilead Sciences | None | $113 | 5 payments
|
| Abbvie | Linzess | $94 | 5 payments
|
See all 37 published payments
| Gilead Sciences | Meals · 2025-11-20 | None | $22 |
| Madrigal Pharmaceuticals | Meals · 2025-11-18 | Rezdiffra | $45 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-11-17 | Xifaxan | $22 |
| Abbvie | Meals · 2025-11-12 | Linzess | $22 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-13 | Xifaxan | $24 |
| Aimmune Therapeutics | Meals · 2025-10-07 | Zenpep | $28 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $22 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-22 | Xifaxan | $23 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-22 | Xifaxan | $2 |
| Abbvie | Meals · 2025-09-11 | Linzess | $15 |
| Aimmune Therapeutics | Meals · 2025-09-10 | Zenpep | $35 |
| Phathom Pharmaceuticals | Meals · 2025-09-09 | Voquezna | $21 |
| Braintree Laboratories | Meals · 2025-09-03 | Suflave | $21 |
| Pfizer | Meals · 2025-09-03 | Xeljanz | $26 |
| Madrigal Pharmaceuticals | Meals · 2025-08-19 | Rezdiffra | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-14 | Entyvio | $34 |
| Gilead Sciences | Meals · 2025-08-06 | None | $18 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-04 | Xifaxan | $23 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-08 | Xifaxan | $24 |
| Janssen Biotech | Education · 2025-06-13 | Tremfya | $99 |
| Janssen Biotech | Meals · 2025-06-06 | Tremfya | $29 |
| Gilead Sciences | Meals · 2025-06-05 | None | $22 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-27 | Xifaxan | $23 |
| Abbvie | Meals · 2025-05-22 | Creon | $23 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-13 | Entyvio | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-05-08 | Dupixent | $116 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $22 |
| Phathom Pharmaceuticals | Meals · 2025-04-16 | Voquezna | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-04-10 | Rezdiffra | $19 |
| Lilly USA | Meals · 2025-04-08 | Omvoh | $33 |
| Madrigal Pharmaceuticals | Meals · 2025-04-02 | Rezdiffra | $33 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-03-28 | Xifaxan | $24 |
| Abbvie | Meals · 2025-03-19 | Linzess | $14 |
| Gilead Sciences | Meals · 2025-03-19 | None | $30 |
| Gilead Sciences | Meals · 2025-03-11 | None | $20 |
| Abbvie | Meals · 2025-03-04 | Linzess | $20 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-01-23 | Xifaxan | $24 |
See earlier years (2024, 2023, 2022, 2021)
2024: $595
| Mauna Kea Technologies | None | $207 | 1 payment
|
| Janssen Biotech | Stelara | $148 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $68 | 3 payments
|
| Abbvie | Linzess | $57 | 3 payments
|
| Gilead Sciences | None | $54 | 2 payments
|
| Orphalan | Cuvrior | $27 | 1 payment
|
| Echosens North America | Fibroscan | $18 | 1 payment
|
| Braintree Laboratories | Sutab | $17 | 1 payment
|
2023: $83
| Abbvie | Mavyret | $59 | 3 payments
|
| Gilead Sciences | None | $24 | 1 payment
|
2022: $23
| Gilead Sciences | None | $23 | 1 payment
|
2021: $184
| Gilead Sciences | None | $160 | 22 payments
|
| AbbVie | Humira | $24 | 1 payment
|
Checkups this office reported
5 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 81.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Age Appropriate Screening ColonoscopyAs Medicare defines this measure | 0% | 698 |
| Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk PatientsAs Medicare defines this measure | 100% | 91 |
| Colon cancer screeningEligible adults who got a colon cancer test | 100%That's most of the people this applied to. | 396 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 1,444 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,120 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Improved the patient portal
- Offers telehealth visits
Professional record
- NPI
- 1821386962
- Licence
- CA 158918California A158918: Current · expires 2028-10-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2331 Montpelier Dr Ste B, San Jose, CA, 95116
- NPI first listed
- 2011-07-11
- NPI last updated
- 2019-10-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 231 Oconnor Dr, San Jose, CA, 95128 · 2331 Montpelier Dr Ste B, San Jose, CA, 95116
This office lists an electronic records connection.